Ken Griffin Teva Pharmaceutical Industries LTD Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $1.02 Million - $1.22 Million	-64,500 Reduced 10.94%	525,100 $9.46 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $10.9 Million - $14.9 Million	-853,800 Reduced 59.15%	589,600 $9.58 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $3.64 Million - $4.93 Million	341,400 Added 30.98%	1,443,400 $20.4 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $4 Million - $5.23 Million	-492,300 Reduced 30.88%	1,102,000 $11.5 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $1.72 Million - $2.46 Million	-230,300 Reduced 12.62%	1,594,300 $16.3 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $3.23 Million - $4.24 Million	-448,100 Reduced 19.72%	1,824,600 $13.7 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $15.5 Million - $21 Million	-1,849,800 Reduced 44.87%	2,272,700 $20.1 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $4.21 Million - $5.01 Million	529,000 Added 14.72%	4,122,500 $37.6 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $6.27 Million - $10.9 Million	-914,400 Reduced 20.28%	3,593,500 $29 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.